Cited by 815Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalitiesChromatin Remodeling and Cancer

Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome

Open access
Davoli, Teresa, Xu, Andrew Wei, Mengwasser, Kristen E., Sack, Laura M., Yoon, John C., Park, Peter J., Elledge, Stephen J.·2013·Cell

Abstract

Aneuploidy has been recognized as a hallmark of cancer for more than 100 years, yet no general theory to explain the recurring patterns of aneuploidy in cancer has emerged. Here, we develop Tumor Suppressor and Oncogene (TUSON) Explorer, a computational method that analyzes the patterns of mutational signatures in tumors and predicts the likelihood that any individual gene functions as a tumor suppressor (TSG) or oncogene (OG). By analyzing >8,200 tumor-normal pairs, we provide statistical evidence suggesting that many more genes possess cancer driver properties than anticipated, forming a continuum of oncogenic potential. Integrating our driver predictions with information on somatic copy number alterations, we find that the distribution and potency of TSGs (STOP genes), OGs, and essential genes (GO genes) on chromosomes can predict the complex patterns of aneuploidy and copy number variation characteristic of cancer genomes. We propose that the cancer genome is shaped through a process of cumulative haploinsufficiency and triplosensitivity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2013.10.011

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Abraxas fits the criteria for a tumor suppressor gene according to TUSON Explorer.

    “Abraxas also fits the criteria as a tumor suppressor gene using the Tumor Suppressor and Oncogene (TUSON) Explorer, a recently proposed computational method for predicting oncogene/tumor suppressor genes (Davoli et al., 2013).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Davoli, T., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J., & Elledge, S. J.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Elledge, Stephen J.
Venue
Cell
Publisher
Elsevier BV
Published
2013-11
Volume
155
Issue
4
Pages
948-962
ISSN
0092-8674 (ISSN-L)
OpenAlex
W1987908519
Cited by
815
References
64
Citations by year
2026: 36 · 2025: 57 · 2024: 63 · 2023: 69 · 2022: 68 · 2021: 68 · 2020: 76 · 2019: 68 · 2018: 76 · 2017: 62 · 2016: 60 · 2015: 69 · 2014: 40 · 2013: 2
FWCI
20.03
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Defense
  • Howard Hughes Medical Institute
  • Wellcome Trust
  • National Institutes of Health
  • National Institute of General Medical Sciences (T32GM007753, R01GM044664)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08DK081612)
  • U.S. National Library of Medicine (U54LM008748)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
aneuploidy, haploinsufficiency, cancer genome, tumor suppressor, oncogenes, mutational signatures, cancer driver genes, essential genes, somatic copy number alterations, copy number variation
MeSH terms
Algorithms, Aneuploidy, Humans, Neoplasms, Oncogenes, Genes, Tumor Suppressor, Gene Dosage

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review